Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neuroendocrine Tumors × olaparib × Clear all

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 NET 1 Endocrine 1

Conditions

Thymoma 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Mesothelioma 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

olaparib 1 copper dotatate CU-64 1 Tomography, Emission-Computed, Single-Photon 1 Positron Emission Tomography Computed Tomography 1 PM 01183 1 Lutetium-177 1 Iodine-124 1 Iodine-123 1 Injections 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04375267 2023-11-14

LuPARP

Vastra Gotaland Region

Phase 1 Unknown

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡